Skip to content
WeighLab

REMEVi vs Heva Health

Compare the prices, treatment options and tradeoffs that matter before you choose a GLP-1 program.

By The WeighLab Bench. Provider verification dates appear below.

REMEVi

Provider comparison

Spanish- and English-speaking shoppers who want LegitScript-certified compounded GLP-1 care in their own language.

Semaglutide / month
$199 per 4 weeksMonth-to-month, same at every dose; $159 per 4 weeks on a 24-week plan paid up front, compounded
Tirzepatide / month
$269 per 4 weeksMonth-to-month, same at every dose; $225 per 4 weeks on a 24-week plan paid up front, compounded
Index 82/100 · Grade B−Checked October 2026

Heva Health

Provider comparison

Readers choosing between monthly compounded treatment and a longer discounted commitment who want named clinical leadership and clear separate branded-care charges.

Semaglutide / month
$199/moMonth-to-month (all doses, compounded; $189 on 3-month commitment, $174 on 6-month)
Tirzepatide / month
$399/moMonth-to-month (all doses, compounded; $339 on 3-month commitment, $299 on 6-month)
Index 82/100 · Grade B−Checked October 2026

We may earn a commission if you sign up through a provider link, at no extra cost to you. Compensation does not change scores. How we earn money.

The comparison in brief

Both score 82/100 on the Cost-Efficiency Index. There is no score winner; compare the treatment you need, billing terms and state availability.

Check the difference in state access

REMEVi
49 states + DC
Heva Health
Direct Access nationwide where licensed; tirzepatide excludes AK, AR, IN and SC; Concierge Care in 12 states

The better fit depends on what is included in your quote. A lower advertised price can require prepayment, apply to a starting dose or leave out a separate fee.

How the comparison is scored

Costs & coverage

Published prices with their terms intact. Annual estimates account for billing frequency and known fixed required fees; they are not a treatment quote.

REMEVi

Heva Health

Semaglutide / month
REMEVi: $199 per 4 weeksMonth-to-month, same at every dose; $159 per 4 weeks on a 24-week plan paid up front, compounded
Heva Health: $199/moMonth-to-month (all doses, compounded; $189 on 3-month commitment, $174 on 6-month)
Tirzepatide / month
REMEVi: $269 per 4 weeksMonth-to-month, same at every dose; $225 per 4 weeks on a 24-week plan paid up front, compounded
Heva Health: $399/moMonth-to-month (all doses, compounded; $339 on 3-month commitment, $299 on 6-month)
Semaglutide / year (modeled)
REMEVi: $2,58713 charges
Heva Health: $2,388
Tirzepatide / year (modeled)
REMEVi: $3,49713 charges
Heva Health: $4,788
State availability
REMEVi: 49 states + DC
Heva Health: Direct Access nationwide where licensed; tirzepatide excludes AK, AR, IN and SC; Concierge Care in 12 states
Oral / sublingual option listed
REMEVi: Yes
Heva Health: Yes
Brand-name access listed
REMEVi: Not confirmed
Heva Health: Yes
Provider facts checked
REMEVi: October 2026
Heva Health: October 2026

Comparing different billing plans? See what a GLP-1 monthly price can leave out, or calculate the monthly cost.

Which program fits your priorities?

The strengths and limitations behind each provider's score. Read the full review before deciding.

REMEVi

Spanish- and English-speaking shoppers who want LegitScript-certified compounded GLP-1 care in their own language.

Reasons to consider it

  • A genuinely flat rate: 'the same price at every dose', stated as such, with no dose upcharge and no introductory rate to step off
  • Longer terms are published openly rather than used as a teaser: semaglutide falls to $169 every 4 weeks on a 12-week plan and $159 on a 24-week plan
  • A daily oral semaglutide tablet is offered alongside the injection

What to weigh up

  • Billing runs every 4 weeks, so a year of month-to-month care is 13 charges, and the lowest $159 rate needs 24 weeks paid up front
  • No FDA-approved brand-name pathway — the Wegovy and Ozempic pages are comparison content, not products
  • Compounded semaglutide and tirzepatide are not FDA-approved finished products

Heva Health

Readers choosing between monthly compounded treatment and a longer discounted commitment who want named clinical leadership and clear separate branded-care charges.

Reasons to consider it

  • Publishes monthly, three-payment and six-payment prices for both compounded injections
  • The compounded price stays the same at every dose
  • Offers branded Wegovy, Zepbound and oral Foundayo prescribing with the medication charge separated

What to weigh up

  • Discounted three- and six-month plans can carry an early termination fee or remaining-term balance
  • Tirzepatide is not available in Alaska, Arkansas, Indiana or South Carolina
  • Branded care at $99 monthly excludes the medication bill

Explore the six scoring factors

Scores run from 0 to 100. A higher factor score reflects our published value criteria; it is not a clinical endorsement.

REMEViHeva Health
Normalized Cost/Month
REMEVi:
74/100
Heva Health:
78/100
Price Transparency
REMEVi:
94/100
Heva Health:
94/100
Nationwide Access
REMEVi:
86/100
Heva Health:
78/100
Formulation Options
REMEVi:
77/100
Heva Health:
95/100
Clinical Oversight
REMEVi:
87/100
Heva Health:
87/100
Contract Flexibility
REMEVi:
69/100
Heva Health:
55/100

Before you sign up

  • Confirm your totalAsk about dose changes, membership, labs, shipping and cancellation terms.
  • Check treatment accessState coverage and medical eligibility can differ by medication and formulation.
  • Understand the medicationCompare compounded and brand-name options. Compounded drugs are not FDA-approved.

Keep comparing

More provider matchups
Choose a different comparison

Provider information reflects public disclosures at the verification dates shown. Prices and availability change; confirm current terms before paying. This comparison is for information, not medical advice. A licensed clinician determines whether treatment is appropriate.